NUVB
Nuvation Bio Inc
NYSE: NUVB · HEALTHCARE · BIOTECHNOLOGY
$4.34
-4.82% today
Updated 2026-04-29
Market cap
$1.51B
P/E ratio
—
P/S ratio
23.99x
EPS (TTM)
$-0.60
Dividend yield
—
52W range
$2 – $10
Volume
4.2M
Nuvation Bio Inc (NUVB) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-616000.00 | $-24.43M | $-36.53M | $-68.19M | $-96.11M | $-68.00M | $-130.41M | $-173.43M |
| Capital expenditures | $659000.00 | $659000.00 | $145000.00 | $282000.00 | $370000.00 | $69000.00 | $162000.00 | $354000.00 |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | $2.20M | $9.27M | $16.29M | $19.51M | $32.27M | $35.89M |
| Free cash flow | $-1.27M | $-25.09M | $-36.67M | $-68.47M | $-96.48M | $-68.07M | $-130.57M | $-173.78M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $102.67M | $-31.32M | — | — | — |